CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 289 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 1.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $78,345,151 | +29.0% | 2,411,362 | 0.0% | 4.55% | +8.5% |
| Q1 2024 | $60,742,209 | -22.4% | 2,411,362 | 0.0% | 4.19% | -13.4% |
| Q4 2023 | $78,321,038 | -14.9% | 2,411,362 | -28.6% | 4.84% | -28.9% |
| Q3 2023 | $92,044,178 | +22.5% | 3,377,768 | 0.0% | 6.80% | +17.1% |
| Q2 2023 | $75,155,338 | +2.7% | 3,377,768 | 0.0% | 5.81% | +20.3% |
| Q1 2023 | $73,162,455 | +6.6% | 3,377,768 | 0.0% | 4.83% | +12.7% |
| Q4 2022 | $68,602,468 | -19.6% | 3,377,768 | +1.5% | 4.28% | +5.3% |
| Q3 2022 | $85,324,000 | +42.0% | 3,327,768 | +31.7% | 4.07% | +37.5% |
| Q2 2022 | $60,080,000 | – | 2,526,490 | – | 2.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,360,485 | $186,021 | 8.91% |
| Novo Holdings A/S | 3,377,768 | $75,155,338 | 5.81% |
| Parallel Advisors, LLC | 3,726,565 | $82,916,071 | 2.67% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $791 | 2.14% |
| S&T BANK/PA | 347,260 | $7,727 | 1.39% |
| FAS Wealth Partners, Inc. | 310,771 | $6,914,655 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,112,500 | 0.83% |
| Granite Investment Partners, LLC | 792,519 | $17,633,548 | 0.70% |
| Bridge City Capital, LLC | 60,632 | $1,349,062 | 0.64% |
| AJ WEALTH STRATEGIES, LLC | 509,934 | $11,346,032 | 0.55% |